Last Updated: July 24, 2026
At eJPort (operated by ScopeMed BV), we are committed to ensuring that our website is accessible to everyone, regardless of ability or technology. We believe that all users should have equal access to information and services, and we strive to create an inclusive digital environment.
We are continuously working to improve the accessibility of our website to ensure that it meets or exceeds the standards set by the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA.
Our website includes the following accessibility features to ensure a better experience for all users:
Our website can be fully navigated using a keyboard alone. All interactive elements (links, buttons, forms) are accessible via the Tab key, and active elements are visually highlighted.
Our code is structured to work with popular screen readers (including JAWS, NVDA, and VoiceOver). We use semantic HTML, ARIA labels, and proper heading structures to ensure content is announced correctly.
We use high-contrast color combinations, clear typography, and scalable text to ensure content is readable by users with low vision or color blindness. All text can be resized using browser zoom functions.
All meaningful images on our website include descriptive alternative text (alt text) to ensure that users with visual impairments can understand the content through screen readers.
Our pages have a logical structure with clear headings, consistent navigation menus, and descriptive link text. This helps users with cognitive disabilities to understand and navigate our content easily.
We aim to comply with the following standards:
We regularly test our website using automated tools (such as WAVE, Lighthouse, and axe) and manual testing to identify and address accessibility barriers.
Our website is designed to be compatible with:
Note: Our website is tested on the latest versions of all major browsers and operating systems.
Despite our best efforts, some parts of our website may not be fully accessible due to limitations in existing technology or third-party integrations. We are actively working to address the following known issues:
If you encounter any accessibility barriers, please contact us (see section 7 below) — we take all reports seriously and will address them promptly.
We view accessibility as an ongoing journey, not a destination. We welcome your feedback and are committed to continuously improving our website's accessibility.
Here is how we are working to improve:
If you experience any difficulty accessing our website, have questions about our accessibility features, or would like to provide feedback, please contact us:
Company: ScopeMed BV
Address: 14 Rue de Grand-Bigard, 1082 Brussels, Belgium
Email: info@ejport.com
Phone: +32 16 84 37 16
We aim to respond to all accessibility-related inquiries within 5 business days.
This Accessibility Statement is reviewed and updated regularly. The "Last Updated" date at the top of this page indicates when the statement was last revised. We encourage you to review this page periodically to stay informed about our accessibility efforts.
© 2012-2026Company: ScopeMed BV Address: 14 Rue de Grand-Bigard, 1082 Brussels, Belgium Tax Number: BE0798843795 Email:info ejport.comTel: +32 16 84 37 16 |
Links BiblioMed Database Author Tools |
Company About Us Job / Careers Contact Us |
Content Links Home eJM - Journal Management System DOI for Articles Journal Promotion |
𝕏 |
|
| Cookie Settings | Cookie Policy GDPR / Privacy Policy Terms & Conditions Accessibility | ||||